Delaware judge allows 70,000 Zantac cancer lawsuits to proceed, allowing experts to testify on drug's potential risks.
A Delaware judge has allowed over 70,000 lawsuits alleging that the discontinued heartburn drug Zantac caused cancer to proceed, ruling that expert witnesses can testify in court regarding the drug's potential cancer risks. The decision is a setback for former Zantac makers GSK, Pfizer, Sanofi, and Boehringer Ingelheim, who argued that the expert witnesses' opinions lacked scientific support. The ruling moves the cases one step closer to trial.
June 01, 2024
9 Articles